Potential Kodak deal paused until insider trading 'allegations are cleared'

Recent allegations of wrongdoing raise serious concerns, says the US government department

A government agency said a potential deal to have Eastman Kodak help make generic drugs is being paused until allegations of insider trading at the once mighty photography company are cleared.

Recent allegations of wrongdoing raise serious concerns, said the U.S. International Development Finance Corporation in a tweet late Friday. We will not proceed any further unless these allegations are cleared.

The International Development Finance Corporation did not respond for a request for comment Saturday.

Kodak, which is based in Rochester, New York, declined to comment.

Last month, the International Development Finance Corporation signed a letter of intent to potentially give Kodak a $765